One Ottawa hospital is buffing up its cleaning staff to prepare for any oncoming spread of C. difficile after recent outbreaks in Kingston and Niagara. Currently dealing with four cases of the ...
Dentists renewing their licenses in Georgia will need to complete a new survey to help the state better understand antibiotic prescribing habits. 11Alive Investigates learned about the Department of ...
An Ohio University researcher is leading a study that could pave the way for new treatments to prevent dangerous infections in heart failure patients. The American Heart Association has awarded a ...
7.2500 -6.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.1160 -6.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.9821 -6.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.8481 -6.9500 0.0000 ...
There are about half a million C. diff infections every year in the United States. About 30,000 people die from them annually. But if you’ve had C. diff, you’re more likely to get it again. About 1 in ...
While antibiotics and gastric acid-suppressing drugs are known to be risk factors for Clostridioides difficile infection, other commonly prescribed non-antibiotic drugs were found to be culprits, ...
DEAR DR. ROACH: I read your recent column about a person who was refusing antibiotics due to a fear of a Clostridioides difficile (C. diff) recurrence. I am interested in your thoughts regarding ...
Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of strep throat from Mundo’s first-grade class — routine enough, treatable with ...
An experimental antibiotic called EVG7 has shown promise against gram-positive bacterium Clostridioides difficile, the leading cause of healthcare and antibiotic-associated diarrhea in the US and ...
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile - commonly known as C. diff - are a serious and persistent problem for patients and ...
Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...
Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results